TILT Holdings Inc. (“TILT” or the “Company”) (CSE:TILT, OTCQB:TLLTF), a foundational technology cannabis platform comprised of assets to support brands worldwide, announced today that its subsidiary Jupiter Research, LLC (“Jupiter”) and Convectium Jacksam Corporation (OTCQB: JKSM) (“Convectium”), an automation solutions company providing machines and equipment to legalized and licensed CBD and THC companies, have signed a memorandum of understanding to create an exclusive proprietary cartridge and POD pre-racking solution, allowing producers and extractors to scale to meet rapidly increasing demand.
Jupiter is a leading inhalation technology company, now exclusively providing CCELL® pre-rack cartridges, disposables and PODS for use with Convectium filling and capping equipment. Automation allows concentrate producers to scale quickly and profitably while reducing costs, risk and waste. Jupiter and Convectium’s pre-rack solution helps businesses compete effectively in cannabis and CBD extracts, a crucial segment of the rapidly growing industry in the United States.
“Existing competitors don’t offer pre-racked inhalation devices or the breadth, speed and cost advantages of Convectium’s fully automated solution. We are excited to be at the forefront of innovation with them to bring newer and more efficient tools to the cannabis industry through this relationship,” said Mark Scatterday, interim CEO of TILT. “CCELL® and Jupiter continue to be the leading technology in the cannabis and CBD space, now with a scalable pre-rack solution to meet our customers’ rapidly increasing demand.”
The Ultimate Automation Solution includes pre-racked Jupiter CCell® cartridge trays and Convectium’s filling and capping machines, allowing cannabis and CBD producers and extractors to save time and money through automatic filling and capping.
“Automation is the rocket fuel to propel next-gen cannabis and CBD brands to stratospheric levels,” said Convectium CEO Mark Adams. “The legal cannabis industry is wide open for disruption and the future will be built on ground-breaking opportunities like this that deliver new solutions for scale, reliability, speed, and profitability.”
Cannabis and CBD oil producers and extractors can pre-order the pre-rack solution by contacting either Jupiter or Convectium.
TILT Holdings serves cannabis brands worldwide through a strong network of portfolio companies committed to technological innovations that support long-term success. TILT services more than 2,000 brands and cannabis retailers across 33 states in the U.S., as well as in Canada, Israel, Mexico, South America and the European Union. As a market leader in cannabis technology and related products and services, the Company’s core assets include wholly-owned subsidiaries Jupiter, a company that focuses on the vast potential of inhalation through innovative design, development and manufacturing; Blackbird, a company that provides operations and software solutions for wholesale and retail distribution; and Baker, a CRM platform helping dispensaries grow their business. The Company also owns cannabis operations in states including Massachusetts, led by Commonwealth Alternative Care, Inc.; and in Pennsylvania, led by Standard Farms, LLC. Headquartered in Cambridge, Massachusetts, with offices throughout the U.S., and London, TILT has over 400 employees and has sales in the U.S., Canada and Europe. For more information, visit www.tiltholdings.com.
Convectium Jacksam Corporation (OTCQB: JKSM) designs, manufactures and sells automation equipment for cannabis and CBD oil producers. Offering the only UL certified filling and capping machines specifically designed for the cannabis industry, Convectium machines work with nearly any commercially available cartridge, POD, vape or other inhalation device. As a first mover in large-scale post-extraction technology, Convectium holds numerous global patents and serves the most prestigious cannabis and CBD companies in the world. For more information, visit https://get.convectium.com/.
SVP of Business Development
Phone: (303) 872-7255
Mark Adams, CEO
This news release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of TILT, and includes statements about, among other things, future developments, the future operations, strengths and strategy of TILT. Generally, forward looking information can be identified by the use of forward looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the use of proceeds of the Financing, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.
Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that they it be completed on the terms described above and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.
By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of material factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially from those discussed in the forward-looking statements.
The CSE has neither approved nor disapproved the contents of this news release.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).